Financials Irwin Naturals Inc.

Equities

IWIN

CA46414Q1054

Pharmaceuticals

End-of-day quote Canadian Securities Exchange 06:00:00 2024-05-06 pm EDT 5-day change 1st Jan Change
0.3 USD 0.00% Intraday chart for Irwin Naturals Inc. 0.00% +57.89%

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 3.787 7.816
Enterprise Value (EV) 1 13.14 28.34
P/E ratio 105 x -0.94 x
Yield - -
Capitalization / Revenue 0.04 x 0.09 x
EV / Revenue 0.13 x 0.32 x
EV / EBITDA 1.48 x 11 x
EV / FCF 1,482,612 x -16,372,244 x
FCF Yield 0% -0%
Price to Book 0.26 x 0.34 x
Nbr of stocks (in thousands) 1,200 2,994
Reference price 2 3.156 2.611
Announcement Date 5/2/22 5/25/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales 1 87.86 89.38 100.3 89.47
EBITDA 1 6.515 7.718 8.854 2.569
EBIT 1 6.309 7.605 8.732 2.261
Operating Margin 7.18% 8.51% 8.7% 2.53%
Earnings before Tax (EBT) 1 5.989 7.356 7.928 -0.97
Net income 1 5.915 7.24 8.615 -3.992
Net margin 6.73% 8.1% 8.59% -4.46%
EPS 2 5.920 7.240 0.0300 -2.790
Free Cash Flow - 7.293 8.863 -1.731
FCF margin - 8.16% 8.83% -1.94%
FCF Conversion (EBITDA) - 94.5% 100.1% -
FCF Conversion (Net income) - 100.73% 102.87% -
Dividend per Share 2 5.850 6.950 - -
Announcement Date 8/13/21 8/13/21 5/2/22 5/25/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 21.81 22.02 23.04 22.51 22.13 19.07
EBITDA 1 - 1.09 -2.237 -0.696 -1.224 -1.651
EBIT 1 - 0.622 -1.813 -1.465 -1.851 -2.285
Operating Margin - 2.82% -7.87% -6.51% -8.36% -11.98%
Earnings before Tax (EBT) 1 - 0.441 -4.082 -8.337 -7.953 -3.023
Net income 1 0.039 -0.673 -4.66 -7.626 -5.323 -1.736
Net margin 0.18% -3.06% -20.22% -33.88% -24.05% -9.1%
EPS 2 - -0.3900 -0.0124 -0.0234 - -0.5600
Dividend per Share - - - - - -
Announcement Date 8/29/22 11/30/22 5/25/23 5/30/23 8/25/23 11/22/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 12.2 9.2 9.35 20.5
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) 1.877 x 1.193 x 1.056 x 7.991 x
Free Cash Flow - 7.29 8.86 -1.73
ROE (net income / shareholders' equity) - 47.6% 53.4% -9.43%
ROA (Net income/ Total Assets) - 12.1% 13% 2.24%
Assets 1 - 59.7 66.02 -178
Book Value Per Share 2 15.60 14.80 12.10 7.770
Cash Flow per Share 2 0.3700 0.4400 0.5200 0.2700
Capex 1 0.04 0.13 0.05 0.15
Capex / Sales 0.04% 0.15% 0.05% 0.16%
Announcement Date 8/13/21 8/13/21 5/2/22 5/25/23
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. IWIN Stock
  4. Financials Irwin Naturals Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW